Skip to main content
logo

Cheng Li

Stock Analyst at Oppenheimer

(0.86)
# 3,987
Out of 5,157 analysts
3
Total ratings
33.33%
Success rate
-4.43%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology

Stocks Rated by Cheng Li

Wave Life Sciences
Dec 16, 2025
Maintains: Outperform
Price Target: $24 → $32
Current: $14.08
Upside: +127.27%
Vaxart
Aug 15, 2024
Initiates: Outperform
Price Target: $4
Current: $0.77
Upside: +418.00%